Abstract
A model is proposed which is based on the assumption that acne is due to infection of functionally blocked pilosebaceous follicles by propionibacteria. Noninflamed lesions, which are first visible during the adrenarche in acne-prone individuals, do not contain propionibacteria. Comedogenesis appears to be independent of bacterial infection and may be driven by high levels of bioactive interleukin-1α derived from ductal hyperkeratinocytes. The stimulus which triggers interleukin-1α production is unknown. Formalin killed Propionibacterium acnes failed to stimulate production of the cytokine by cultured human keratinocytes in vitro.
Inflamed lesions are thought to arise from microcomedones, but the initiating events are unknown. Evidence that propionibacteria are involved in the generation of inflammatory lesions is inconclusive. The cellular infiltrate is consistent with a type IV hypersensitivity response to one or more persistent lesional antigens, not necessarily bacterial. The potent adjuvant activity of P. acnes would up-regulate the immune response to any antigen which came into contact with the mononuclear cell infiltrate.
Antibiotics are widely used in the treatment of acne, and their effects in selecting a predominantly resistant commensal population are well recognized. Although they reduce numbers of propionibacteria on the skin, other modes of action may contribute to or explain their therapeutic efficacy. At a time when there is global concern that antibiotic resistance rates in common bacterial pathogens may threaten our future ability to control bacterial infections, practices which promote the spread of antibiotic-resistant bacteria must be fully justified. A thorough reappraisal of the role of propionibacteria in acne is overdue. It is likely that further experimental work is needed to confirm or refute that P. acnes is aptly named.
This is a preview of subscription content, access via your institution.



References
Stewart M.E., Downing D.T., Cook J.S., et al. Sebaceous gland activity and serum dehydroepiandrosterone sulphate levels in boys and girls. Arch Dermatol 1992; 128: 1345–1348
Yamamoto A., Ito M. Sebaceous gland activity and urinary androgen levels in children. J Dermatol Sci 1992; 4: 98–104
Lavker R.M., Leyden J.J., McGinley K.J. The relationship between bacteria and the abnormal follicular keratinisation in acne vulgaris. J Invest Dermatol 1981; 77: 325–330
Pierard G.E., Pierard-Franchimont C., Le T. Seborrhoea in acne-prone and acne-free patients. Dermatologica 1987; 175: 5–9
Guy R., Kealey T. Modelling the infundibulum in acne. Dermatology 1998; 196: 32–37
Walters C.E., Ingham E., Eady E.A., et al. In vitro modulation of keratinocyte-derived interleukin-1α (IL-1α) and peripheral blood mononuclear cell-derived IL-ß release in response to cutaneous commensal microorganisms. Infect Immun 1995; 63: 1223–1228
Marples R.R., Williamson P. Effects of systemic demethylchlortetracycline on human cutaneous microflora. Appl Microbiol 1969; 18: 228–234
Miskin J.E., Farrell A.M., Cunliffe W.J., et al. Propionibacterium acnes, a resident of lipid-rich human skin, produces a 33 kDA extracellular lipase encoded by gehA. Microbiology 1997; 143: 1745–1755
Fulton J.E., Noble N.L., Bradley S., et al. The glycerol ester hydrolase (EC 3.1.1.3) from Corynebacterium acnes: a serine lipase. Biochemistry 1974; 13: 2320–2327
Puhvel S.M., Sakamoto M. A reevaluation of fatty acids as inflammatory agents in acne. J Invest Dermatol 1977; 68: 93–97
Weeks J.G., McCarty L., Fulton J.E. The inability of a bacterial lipase inhibitor to control acne vulgaris. J Invest Dermatol 1977; 69: 236–243
Leeming J.P., Holland K.T., Cunliffe W.J. The pathological and ecological significance of microorganisms colonising acne vulgaris comedones. J Med Microbiol 1985; 20: 11–16
Pochi P.E., Strauss J.S., Downing D.T. Skin surface lipid composition, acne, pubertal development and urinary excretion of testosterone and 17-ketosteroids in children. J Invest Dermatol 1977; 69: 485–489
Lucky A.W., Biro F.M., Huster G.A., et al. Acne vulgaris in early adolescent boys: correlations with pubertal maturation and age. Arch Dermatol 1991; 127: 210–216
Lucky A.W., Biro F.M., Simbartl L.A., et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997; 130: 30–39
Aldana O.L., Holland D.B., Cunliffe W.J. Precomedonal events in acne. J Invest Dermatol 1996; 104: 488
Downing D.T., Stewart M.E., Wertz P.W., et al. Essential fatty acids and acne. J Am Acad Dermatol 1986; 14: 221–225
Bomalaski J.S., Steiner M.R., Simon P.L., et al. IL-1 increases phospholipase A2 activating-protein, and release of linoleic acid from murine T helper cell line EL-4. J Immunol 1992; 148: 15–60
Camacho M., Godessart N., Vila L. IL-1 increases the ability of human endothelial cells to transform linoleic acid into monohydroxy-isomers and their incorporation into lipid. Adv Exp Med Biol 1997; 400B: 647–654
Baldie G., Kaimakamis D., Rotondo D. Fatty acid modulation of cytokine release from human monocytic cells. Biochim Biophys Acta 1993; 1179: 125–133
Stewart M.E. Sebaceous gland lipids. Semin Dermatol 1992; 11: 100–105
Kirschbaum J.D., Kligman A.M. The pathogenic role of Corynebacterium acnes in acne vulgaris. Arch Dermatol 1963; 88: 832–833
De Young L.M., Young J.M., Ballaron S.J., et al. Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne. J Invest Dermatol 1984; 83: 394–398
De Young L.M., Spires D.A., Ballaron S.J., et al. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system. J Invest Dermatol 1985; 85: 255–258
Dalziel K., Dykes P.J., Marks R. Inflammation due to intra-cutaneous implantation of stratum corneum. Br J Exp Pathol 1984; 65: 107–115
Dalziel K., Dykes P.J., Marks R. The effect of tetracycline and erythromycin in a model of acne-type inflammation. Br J Exp Pathol 1987; 68: 67–70
Norris J.F.B., Cunliffe W.J. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988; 118: 651–659
Layton A.M., Morris C., Cunliffe W.J., et al. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 1998; 7: 191–197
Roszkowski W., Roszkowski K., Ko H.L., et al. Immunomodulation by propionibacteria. Zentralbl Bakteriol 1990; 274: 289–298
Webster G.F., Leyden J.J., Musson R.A., et al. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun 1985; 49: 116–121
Kersey P., Sussman M., Dahl M. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol 1980; 103: 651–655
Ingham E. The immunology of Propionibacterium acnes and acne. Curr Opin Infect Dis 1999; 12: 191–197
Leyden J.J., McGinley K.J., Mills O.H., et al. Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol 1975; 65: 379–381
Agache P., Blanc D., Barrand C., et al. Sebum levels during the first years of life. Br J Dermatol 1980; 103: 643–649
Leyden J.J., McGinley K.J., Mills O.H., et al. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65: 382–384
Pochi P.E., Strauss J.S., Downing D.T. Age-related changes in sebaceous gland activity. J Invest Dermatol 1979; 73: 108–111
Puhvel S.M., Reisner R.M., Amirian D.A. Quantification of bacteria in isolated pilosebaceous follicles in normal skin. J Invest Dermatol 1975; 65: 525–531
Leeming J.P., Holland K.T., Cunliffe W.J. The microbial colonisation of inflamed acne vulgaris lesions. Br J Dermatol 1988; 118: 203–208
Bojar R.A., Cunliffe W.J., Holland K.T. The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol 1995; 132: 204–208
Eady E.A., Cove J.H., Holland K.T., et al. Superior anti-bacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracyclinetreated acne patients. Br J Dermatol 1990; 122: 233–244
Cove J.H., Cunliffe W.J., Holland K.T. Acne vulgaris: is the bacterial population size significant? Br J Dermatol 1980; 102: 277–280
Garner S.E., Eady E.A., Popescu C., et al. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2000; 2: CD002086
Pulverer G., Ko H.L., Beuth J., et al. Tetracycline and 13-cis retinoic acid inhibit production and activity of granulocyte activating factor (GAF) from Propionibacterium acnes. Zentralbl Bakteriol 1990; 273: 362–368
van Vlem B., Vanholder R., de Paepe P., et al. Immunomodulating effects of antibiotics: literature review. Infection 1996; 24: 275–291
Humbert P., Treffel P., Chapuis J.F., et al. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691–697
Labro M.T. Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998; 41 Suppl. B: 37–46
Webster G.F., Toso S.M., Hegemann L. Inhibition of a model of granuloma formation by tetracyclines and ciprofloxacin. Arch Dermatol 1994; 130: 748–752
Plewig G., Schöpf E. Anti-inflammatory effects of antimicrobial agents: an in vivo study. J Invest Dermatol 1975; 65: 532–536
Miyachi Y., Yoshioka A., Imamura S., et al. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986; 86: 449–453
Golub L.M., Lee H.M., Ryan M.E., et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998; 12: 12–26
Meneguzzi G., Partouche O., Ortonne J.P. Effect of minocycline on proliferation and differentiation of cultured normal human keratinocytes [abstract]. J Invest Dermatol 1997; 108: 377
Saint-Marie I., Tenaud I., Jumbou O., et al. Minocycline modulation of alpha-MSH production by keratinocytes in vitro. Arch Dermatol Venereol 1999; 79: 265–267
Eady E.A., Cove J.H., Holland K.T., et al. Erythromycin resistant propionibacteria in antibiotic-treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51–57
Leyden J.J., McGinley K.J., Cavalieri S., et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41–45
Bojar R.A., Eady E.A., Jones C.E., et al. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329–336
Eady E.A., Bojar R.A., Jones C.E., et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134: 107–113
Verschoore M., Poncet M., Krebs B., et al. Circadian variations in the number of actively secreting sebaceous follicles and androgen circadian rhythms. Chronobiol Int 1993; 10: 349–359
McGinley K.J., Webster G.F., Ruggieri M.R., et al. Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1980; 12: 672–675
Cove J.H., Holland K.T., Cunliffe W.J. An analysis of sebum excretion rate, bacterial population and the production rate of free fatty acids on human skin. Br J Dermatol 1980; 103: 383–386
Kearney J.N., Ingham E., Cunliffe W.J., et al. Correlations between human skin bacteria and skin lipids. Br J Dermatol 1984; 110: 593–599
Stewart M.E., Downing D.T. Measurement of sebum secretion rates in young children. J Invest Dermatol 1985; 84: 59–61
Green S.C., Stewart M.E., Downing D.T. Variations in sebum fatty acid composition among adult humans. J Invest Dermatol 1984; 83: 114–117
Williams M., Cunliffe W.J. Explanation for pre-menstrual acne. Lancet 1973; 2 (7837): 1055–1057
Gardner K.J., Cunliffe W.J., Eady E.A., et al. Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris. Br J Dermatol 1994; 131: 649–654
Guin J.D., Lummis W.L. Comedonal levels of free clindamycin following topical treatment with a 1% solution of clindamycin phosphate. J Am Acad Dermatol 1982; 7: 265–268
Standing Medical Advisory Committee The path of least resistance: main report. London: Department of Health, 1998
Acknowledgements
We would like to thank all those colleagues in the Skin Research Centre at Leeds who have contributed so many key studies to the literature on Propionibacterium acnes and with whom we have had many stimulating discussions about why people get spots.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eady, E.A., Cove, J.H. Is Acne an Infection of Blocked Pilosebaceous Follicles?. Am J Clin Dermatol 1, 201–209 (2000). https://doi.org/10.2165/00128071-200001040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200001040-00001